# Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids

> **NCT00109668** · PHASE3 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 415 (—)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** beclomethasone dipropionate (QVAR)

## Key facts

- **NCT ID:** NCT00109668
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07-31
- **Primary completion:** 2006-09-30
- **Final completion:** 2006-09-30
- **Target enrollment:** 415 (—)
- **Last updated:** 2021-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109668, "Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00109668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*